GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.

Diabetes, metabolic syndrome and obesity : targets and therapy（2023）

引用 0|浏览1

暂无评分

摘要

Liraglutide and semaglutide protects skeletal muscle against obesity-induced muscle atrophy via the SIRT1 pathway.

查看译文

关键词

sirt1 pathway,semaglutide,obesity-induced

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要